The HIMS logo organized a smartphone in New York on February 12, 2025.
Bloomberg | Bloomberg | Getty images
Hims and his health He announced Tuesday that he will acquire the European Telesalud Platform Zava in his impulse to expand worldwide.
“We are excited to take this moment to really accelerate both European expansion, but also to use this platform as a accelerator as we move forward to more markets,” said the CEO of Hims & Hers, Andrew Dudum, to CNBC in an interview.
The agreement will close in the middle of the year, according to the company's press release. Although the terms of the acquisition were not revealed, the company said that the details of the transaction will be available in financial dissemination at the closure.
Dudum spoke extensively during the company's first quarter of the company in mid -May about the company's commitment to global expansion.
“Early traction in the United Kingdom gives us confidence that we can climb the platform worldwide and extend the mission to help people around the world,” Dudum said at that time.
HIMS first expanded its global footprint from the United Kingdom in 2021 when it acquired the vertical health platform based in London Honest Health.
The agreement to acquire Zava will expand the company's services to Ireland, France and Germany and increase its active customer base by approximately 50%, adding 1.3 million customers to the existing base of 2.4 million HIMS subscribers.
The CEO of Zava, David Meinertz, who launched the platform in 2011, said the agreement will provide relief to a European medical care system in another other overly.
“Medicines have a more competitive price than in the US. Uu. So that more people can pay it and we are seeing a great demand,” said Meinertz. “Demand increases with additional strains in the legal systems that Telesalud can relieve.”
In the European Union, the legal medical care system generally refers to health insurance with public funds and medical care provision systems within individual member states. These systems are universal, providing comprehensive coverage to citizens and residents, although access and coverage may vary.
After the acquisition is closed, Zava's platforms will maintain their brand for a few “few quarters” before being renamed as Hims & Hers, Dudum said. Meinertz will become general manager of the international company.
Dudum pointed out that although some companies are retreating or retaining their growth perspective given the macroeconomic uncertainty, it has full confidence that advancing is the right decision.
“The price of pharmaceutical products is much more advantageous in the widest Europe in relation to the United States,” Dudum said. “The ability to bring accessible and personalized treatments to customers abroad can be the same or easier than we see at the national level that the prices and complexities of insurance are given and [pharmacy benefit managers] and the price fixation power that exists here. “
